Precigen Inc (NASDAQ: PGEN) kicked off on Tuesday, up 5.54% from the previous trading day, before settling in for the closing price of $4.51. Over the past 52 weeks, PGEN has traded in a range of $0.65-$4.82.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 25.76% over the past five years. While this was happening, its average annual earnings per share was recorded 15.02%. With a float of $147.64 million, this company’s outstanding shares have now reached $297.85 million.
Precigen Inc (PGEN) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Precigen Inc is 50.45%, while institutional ownership is 27.55%. The most recent insider transaction that took place on Aug 28 ’25, was worth 49,491. In this transaction Director of this company bought 10,645 shares at a rate of $4.65, taking the stock ownership to the 202,841 shares. Before that another transaction happened on Aug 19 ’25, when Company’s Director bought 15,360 for $3.20, making the entire transaction worth $49,152. This insider now owns 192,196 shares in total.
Precigen Inc (PGEN) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.09 earnings per share (EPS), higher than consensus estimate (set at -0.09) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
Precigen Inc (NASDAQ: PGEN) Trading Performance Indicators
Take a look at Precigen Inc’s (PGEN) current performance indicators. Last quarter, stock had a quick ratio of 2.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 326.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.43, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.09 in one year’s time.
Technical Analysis of Precigen Inc (PGEN)
Precigen Inc (NASDAQ: PGEN) saw its 5-day average volume 10.48 million, a positive change from its year-to-date volume of 3.86 million. As of the previous 9 days, the stock’s Stochastic %D was 86.00%.
During the past 100 days, Precigen Inc’s (PGEN) raw stochastic average was set at 95.54%, which indicates a significant increase from 94.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.42 in the past 14 days, which was higher than the 0.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.22, while its 200-day Moving Average is $1.56. Nevertheless, the first resistance level for the watch stands at $4.97 in the near term. At $5.18, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.42. If the price goes on to break the first support level at $4.51, it is likely to go to the next support level at $4.27. The third support level lies at $4.06 if the price breaches the second support level.
Precigen Inc (NASDAQ: PGEN) Key Stats
The company with the Market Capitalisation of 1.42 billion has total of 297,973K Shares Outstanding. Its annual sales at the moment are 3,930 K in contrast with the sum of -126,240 K annual income. Company’s last quarter sales were recorded 860 K and last quarter income was -26,640 K.
